Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jorge Bartolomé"'
Autor:
Lucía Paniagua-Herranz, Cristina Díaz-Tejeiro, Adrián Sanvicente, Jorge Bartolomé, Cristina Nieto-Jiménez, Alberto Ocana
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Therapeutic strategies targeting non-adaptive immune cells are currently in clinical development. γδT cells are a small subtype of T cells (1-10% of total T cells) that mediate their effector function without the necessity of the antigen presenting
Externí odkaz:
https://doaj.org/article/7d774cf911074c7781f4b84be65f5c1a
Autor:
Lucía Paniagua-Herranz, Irene Moreno, Cristina Nieto-Jiménez, Esther Garcia-Lorenzo, Cristina Díaz-Tejeiro, Adrián Sanvicente, Bernard Doger, Manuel Pedregal, Jorge Ramón, Jorge Bartolomé, Arancha Manzano, Balázs Gyorffy, Álvaro Gutierrez-Uzquiza, Pedro Pérez Segura, Emiliano Calvo, Víctor Moreno, Alberto Ocana
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 4, p 2222 (2024)
The identification of surfaceome proteins is a main goal in cancer research to design antibody-based therapeutic strategies. T cell engagers based on KLK2, a kallikrein specifically expressed in prostate cancer (PRAD), are currently in early clinical
Externí odkaz:
https://doaj.org/article/c3b8403f9c0744b0baf28b3578bf3380
Autor:
Ignacio Martinez Capella, Sara Gil Useros, Macarena Torrego Ellacuría, Laura Llorente Sanz, Jorge Bartolomé Arcilla, Paloma Flores Navarro, Alicia de Luna Aguilar, Alberto Delgado-Iribarren García-Campero, Javier David Benitez Fuentes, Elvira Baos Muñoz, Alejandro Francisco Jimenez Ortega, Pedro Pérez Segura
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines efficacy and safety have been tested in phase 3 studies in which cancer patients were not included or were underrepresented. Methods: The objective of this study is to
Externí odkaz:
https://doaj.org/article/106d3de9f04449fea57a5cfd285bf249
Autor:
Javier Benítez, Alfonso López de Sa, Julia Tejerina-Peces, Carlos Lombardía Gonzalez, Carmen Toledano, Jorge Bartolomé, Carlos Aguado, Jennifer Olalla, Mateo Paz, Mónica Granja, Paloma Flores, Justo Ortega, Gloria Marquina, Aránzazu Manzano, Alicia de Luna, Araceli Priego, Jesús Fuentes-Antrás, Pedro Pérez-Segura
Publikováno v:
International Journal of Cancer
Coronavirus disease 2019 (COVID‐19) pandemic is affecting a high percentage of the population at an unprecedented rate. Cancer patients comprise a subgroup especially vulnerable to this infection. Herein, we present a prospective analysis of epidem
Autor:
Javier David Benitez Fuentes, Alicia de Luna Aguilar, Alejandro Francisco Jimenez Ortega, Paloma Flores Navarro, Jorge Bartolomé Arcilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren García-Campero, Sara Gil Useros, Ignacio Martinez Capella, Laura Llorente Sanz, Macarena Torrego Ellacuría, Pedro Pérez Segura
Publikováno v:
F1000Research. 11:434
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines efficacy and safety have been tested in phase 3 studies in which cancer patients were not included or were underrepresented. Methods: The objective of this study is to
Autor:
Jorge Bartolome, Consolacion Molto, Javier David Benitez-Fuentes, Gonzalo Fernandez-Hinojal, Aranzazu Manzano, Pedro Perez-Segura, Abhenil Mittal, Faris Tamimi, Eitan Amir, Alberto Ocana
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionIdentification of modulators of the immune response with inhibitory properties that could be susceptible for therapeutic intervention is a key goal in cancer research. An example is the human leukocyte antigen G (HLA-G), a nonclassical ma
Externí odkaz:
https://doaj.org/article/dd488eb0aeb047e5a91a68274cb6c4d3
Autor:
Josefa Vila, Jorge Bartolomé, Joan Fort, Alfons Segarra, Cristina Martinez-Eyarre, Lluis Piera, Fernando Marco, Joaquin Camps, Xavier Argelaguer, Pilar Ruiz, Ernesto Moliner, Antoni Pelegrí, Pilar Chacón, A. Olmos
Publikováno v:
Journal of the American Society of Nephrology. 12:1255-1263
This study investigated the relationship between the circulating levels of the endothelial cell glycoproteins plasminogen activator inhibitor type 1 (PAI-1), tissue plasminogen activator (TPA), and thrombomodulin (TM) and the major vascular risk fact
Autor:
Javier David Benitez Fuentes, Kauzar Mohamed Mohamed, Alicia de Luna Aguilar, Carlos Jiménez García, Kissy Guevara-Hoyer, Miguel Fernandez-Arquero, M Antonia Rodríguez de la Peña, Laura Garciía Bravo, Alejandro Francisco Jiménez Ortega, Paloma Flores Navarro, Jorge Bartolome Arcilla, Bárbara Alonso Arenilla, Elvira Baos Muñoz, Alberto Delgado-Iribarren García-Campero, María Montealegre Sanz, Silvia Sanchez-Ramon, Pedro Perez Segura
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
IntroductionEvidence is scant regarding the long-term humoral and cellular responses Q7 triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in cancer patients after repeated booster doses. The possibility of T-cell
Externí odkaz:
https://doaj.org/article/205ced2c0cb34c1fa28fb27310f18bf2
Autor:
Jorge Bartolomé, Luis Piera, A. Olmos, Luis Armadans, Juan Antonio Rodriguez, Javier Borrellas, Salvador Codina, Eugenio Ferrer
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 15(3)
Background Complications arising from vascular access (VA) are major causes of morbidity in patients on renal replacement therapy (RRT). They contribute to frustration of health care providers and to high medical cost. To prevent failures in the futu
Autor:
Luis Viladomiu, Jaime Guardia, Jorge Bartolomé, Rosendo Jardi, A. Olmos, Rafael Esteban, Juan Antonio Rodriguez, Maria Buti
Publikováno v:
American journal of nephrology. 12(3)
Although the efficacy of hepatitis B vaccines in patients under chronic hemodialysis treatment has been well documented, the persistence of immunity in this population remains largely unknown. In this study we have followed 60 hemodialysis patients u